Nanoparticle mRNA Vaccins against Coronavirus and Emerging Variants (Q3989360)

From EU Knowledge Graph
Revision as of 10:56, 14 December 2021 by DG Regio (talk | contribs) (‎Removed claim: country (P32): Kingdom of the Netherlands (Q213))
Jump to navigation Jump to search
Project Q3989360 in Netherlands
Language Label Description Also known as
English
Nanoparticle mRNA Vaccins against Coronavirus and Emerging Variants
Project Q3989360 in Netherlands

    Statements

    contained in NUTS
    Twente
    0 references
    EU contribution
    293,087.67 Euro
    0 references
    budget
    1,434,730.4 Euro
    0 references
    co-financing rate
    20.428 percent
    0 references
    beneficiary name (string)
    20Med Therapeutics
    0 references
    beneficiary
    Q3986713
    0 references
    coordinate location

    52°14'25.08"N, 6°51'14.04"E
    0 references
    postal code
    7522 NB
    0 references

    Identifiers

    Netherlands Kohesio ID
    OP-2014-2023-Oost-PROJ-01040
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q3989360&oldid=19527672"